Mengyang Peng
About Mengyang Peng
Mengyang Peng is a CDx RA Associate Manager at BeiGene with over 6 years of experience in Class II/III IVD product registration.
Current Position at BeiGene
Mengyang Peng serves as a CDx RA Associate Manager at BeiGene. In this role, he focuses on CDx cooperation and registration strategy. He works closely with the Biomarker team and various IVD companies to find efficient CDx regulatory pathways in China. Peng also supports collaboration between different departments and companies in the evolving field of drug and CDx intersections.
Previous Experience at Cepheid
Mengyang Peng worked at Cepheid from 2018 to 2020 as an RA Specialist. Based in Beijing, China, he specialized in regulatory affairs for two years, contributing his expertise to support the company's regulatory submissions and product registrations in the IVD sector.
Previous Roles at Randox and Naton Medical Group
Before his tenure at Cepheid, Mengyang Peng was a Product Registration Officer at Randox from 2016 to 2018 in Beijing. Prior to that, he served as an International RA Specialist at Naton Medical Group from 2015 to 2016, also based in Beijing. In these roles, he accumulated valuable experience in regulatory affairs and product registration.
Educational Background
Mengyang Peng holds a Master of Science (MS) in Biosciences from the University of Bath, achieved in 2014. He also holds a Bachelor of Engineering (BE) in Bioengineering from China Pharmaceutical University, completed in 2013. His academic background in biosciences and bioengineering underpins his expertise in regulatory affairs for IVD products.
Expertise in IVD Product Registration
Mengyang Peng has over six years of experience in Class II/III IVD product registration. His expertise encompasses developing and implementing strategies for obtaining regulatory approvals as quickly as possible. This extensive experience aids in navigating complex regulatory pathways effectively, ensuring compliance and facilitating market entry for IVD products.